NASDAQ: RNAC
Cartesian Therapeutics Inc Stock Ownership - Who owns Cartesian Therapeutics?

Insider buying vs selling

Have Cartesian Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Emily EnglishChief Operations Officer2025-05-127,500$3.30
$24.75kBuy
Emily EnglishChief Operations Officer2025-04-157,500$3.30
$24.75kBuy
Timothy A. SpringerDirector2025-04-116,412$10.77
$69.08kBuy
Timothy A. SpringerDirector2025-04-1136,338$10.77
$391.47kBuy
Timothy A. SpringerDirector2025-04-10609$10.92
$6.65kBuy
Timothy A. SpringerDirector2025-04-103,451$10.92
$37.70kBuy
Timothy A. SpringerDirector2025-04-1045,144$10.43
$471.03kBuy
Timothy A. SpringerDirector2025-04-107,966$10.43
$83.12kBuy
Timothy A. SpringerDirector2025-04-0931$9.95
$308.48Buy
Timothy A. SpringerDirector2025-04-0941,604$9.43
$392.16kBuy

1 of 9

RNAC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNAC insiders and whales buy or sell their stock.

RNAC Shareholders

What type of owners hold Cartesian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Timothy A. Springer43.06%11,176,469$148.87MInsider
Murat Kalayoglu19.51%5,064,237$67.46MInsider
Elizabeth Hoge19.50%5,061,637$67.42MInsider
Amir Nashat10.31%2,676,234$35.65MInsider
Fmr LLC9.02%2,339,917$31.17MInstitution
Polaris Venture Management Co V LLC7.23%1,876,020$24.99MInsider
Orbimed Advisors LLC7.03%1,825,415$24.31MInsider
Carl L. Gordon7.03%1,825,415$24.31MInsider
Flagship Ventures Fund 2007 LP6.36%1,651,862$22.00MInsider
Rusnano5.69%1,476,177$19.66MInsider

1 of 3

RNAC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNAC13.92%86.08%Net BuyingNet Buying
BNTC85.52%8.18%Net Buying
ABSI63.29%36.71%Net SellingNet Selling
AURA79.28%18.85%Net SellingNet Buying
CAPR31.99%68.01%Net Buying

Cartesian Therapeutics Stock Ownership FAQ

Who owns Cartesian Therapeutics?

Cartesian Therapeutics (NASDAQ: RNAC) is owned by 25.37% institutional shareholders, 156.86% Cartesian Therapeutics insiders, and 0.00% retail investors. Timothy A. Springer is the largest individual Cartesian Therapeutics shareholder, owning 11.18M shares representing 43.06% of the company. Timothy A. Springer's Cartesian Therapeutics shares are currently valued at $145.96M.

If you're new to stock investing, here's how to buy Cartesian Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.